Development and validation of a novel scale for antiretroviral therapy readiness among pregnant women in urban Zambia with newly diagnosed HIV infection

UNAIDS. Global HIV and AIDS statistics - Fact sheet 2021. https://www.unaids.org/en/resources/fact-sheet. Accessed 04 Feb 2022

UNAIDS. Country progress report - Zambia. Global AIDS monitoring 2020. https://www.unaids.org/sites/default/files/country/documents/ZMB_2020_countryreport.pdf. Accessed 04 Feb 2022.

UNICEF. HIV/AIDS 2020. https://www.unicef.org/zambia/hivaids. Accessed on 21 Aug 2022

 Zambia Statistics Agency, Ministry of Health (MOH) Zambia, and ICF 2019. Zambia Demographic Health Survey; 2018

Chimbwandira F, Mhango E, Makombe S, Midiani D, Mwansambo C, Njala J, et al. Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012. Morb Mortal Wkly Rep. 2013;62(8):148–51.

Google Scholar 

WHO. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: WHO; 2012.

Google Scholar 

Ministry of Health Zambia. Lifelong antiretroviral drugs for all HIV positive women in Zambia - Policy guidelines for health facilities in Zambia; 2013 

Shaffer N, Abrams EJ, Becquet R. Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early caution. AIDS. 2014;28(4):599–601.

Article  PubMed  Google Scholar 

Morgenstern T, Grimes D, Grimes R. Assessment of readiness to initiate antiretroviral therapy. HIV Clin Trials. 2002;3(2):168–72.

Article  PubMed  Google Scholar 

Chanda BC, Likwa RN, Zgambo J, Tembo L, Jacobs C. Acceptability of option B+ among HIV positive women receiving antenatal and postnatal care services in selected health centre’s in Lusaka. BMC Pregnancy Childbirth. 2018;18(1):510.

Article  PubMed  PubMed Central  Google Scholar 

Mubiana-Mbewe M, Bosomprah S, Kadota JL, Koyuncu A, Kusanathan T, Mweebo K, et al. Effect of enhanced adherence package on early ART uptake among HIV-positive pregnant women in Zambia: an individual randomized controlled trial. AIDS Behav. 2021;25(3):992–1000.

Article  PubMed  Google Scholar 

Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J, et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017;17(1):94.

Article  PubMed  PubMed Central  Google Scholar 

Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi’s option B+ programme: an observational cohort study. The lancet HIV. 2016;3(4):e175–82.

Article  PubMed  PubMed Central  Google Scholar 

Tenthani LHA, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘option B+’) in Malawi. AIDS. 2014;28(4):589–98.

Article  CAS  PubMed  Google Scholar 

Balfour L, Tasca GA, Kowal J, Corace K, Cooper CL, Angel JB, et al. Development and validation of the HIV medication readiness scale. Assessment. 2007;14(4):408–16.

Article  PubMed  Google Scholar 

Fernández MI, Hosek S, Warren JC, Jacobs RJ, Hernandez N, Martinez J, et al. Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings. AIDS Care. 2011;23(11):1492–9.

Article  PubMed  PubMed Central  Google Scholar 

Hinkin TR. A review of scale development practices in the study of organizations. J Manag. 1995;21(5):967–88.

Google Scholar 

Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Pub Health. 2018. https://doi.org/10.3389/fpubh.2018.00149.

Article  Google Scholar 

Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039–52.

Article  PubMed  Google Scholar 

Bangsberg DR, Liu H. A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behavl Med. 2011;42(3):352–60.

Article  Google Scholar 

Balfour L, Kowal J, Silverman A, Tasca G, Angel J, Macpherson P, et al. A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care. 2006;18(7):830–8.

Article  CAS  PubMed  Google Scholar 

Tremblay CL, Baril J-G, Fletcher D, Kilby D, MacPherson P, Shafran SD, et al. Challenges in initiating antiretroviral therapy in 2010. Canadian J Infect Dis Med Microbiol. 2010;21(Suppl C):1C-15C.

Article  Google Scholar 

Fehr J, Nicca D, Sendi P, Wolf E, Wagels T, Kiss A, et al. Starting or changing therapy–a prospective study exploring antiretroviral decision-making. Infection. 2005;33(4):249–56.

Article  CAS  PubMed  Google Scholar 

Wolff B, Mbonye M, Coutinho A, Amuron B, Nkabala R, Jaffar S, et al. High levels of psychosocial readiness for ART in an African population at the onset of treatment SAHARA-J. J Soc Aspects of HIV/AIDS. 2009;6(4):111.

Article  Google Scholar 

MacDonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW. Predictors of medication adherence in high risk youth of color living with HIV. J Pediatr Psychol. 2009;35(6):593–601.

Article  PubMed  PubMed Central  Google Scholar 

Tessema B, Biadglegne F, Mulu A, Getachew A, Emmrich F, Sack U. Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study. AIDS Res Ther. 2010;7(1):2.

Article  PubMed  PubMed Central  Google Scholar 

Nunnally J, Bernstein I. Psychometric Theory. New York: McGrawHiIl Inc; 1978.

Google Scholar 

 Ong DC. A Primer to Bootstrapping; and an Overview of doBootstrap. Department of Psychology; 2014

Cattell RB. The scree test for the number of factors. Multivar Behav Res. 1966;1(2):245–76.

Article  CAS  Google Scholar 

Popham WJ, Husek TR. Implications of criterion-referenced measurement 1, 2.  Journal of Educational Measurement. 1969 Mar;6(1):1-9

Raykov T, Marcoulides GA. Introduction to psychometric theory. Routledge; 2011

DeVellis RF. Scale Development: Theory and Application. Los Angeles: CA Sage Publications; 2012.

Google Scholar 

Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334.

Article  Google Scholar 

Grimes RM, Grimes DE. Readiness: the state of the science (or the lack thereof). Curr HIV/AIDS Rep. 2010;7(4):245–52.

Article  PubMed  PubMed Central  Google Scholar 

Mutanga JN, Mutembo S, Ezeamama AE, Fubisha RC, Sialondwe D, Simuchembu B, et al. Tracking progress toward elimination of mother to child transmission of HIV in Zambia: findings from the early infant diagnosis of HIV program (2009–2017). J Trop Pediatr. 2020;66(1):56–65.

Article  PubMed  Google Scholar 

Mukose AD, Bastiaens H, Makumbi F, Buregyeya E, Naigino R, Musinguzi J, et al. What influences uptake and early adherence to option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in central Uganda? A mixed methods study. PLoS ONE. 2021;16(5): e0251181.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukosha M, Chiyesu G, Vwalika B. Adherence to antiretroviral therapy among HIV infected pregnant women in public health sectors: a pilot of Chilenje level one hospital Lusaka Zambia. Pan African Med J. 2020;35:111.

Article  Google Scholar 

Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS ONE. 2014;9(11): e111421.

Article  PubMed  PubMed Central  Google Scholar 

Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, Conway T, Webster K, et al. Pathways from HIV-related stigma to antiretroviral therapy measures in the HIV care cascade for women living with HIV in Canada. J Acquir Immune Defic Syndr. 2018;77(2):144.

Article  PubMed  Google Scholar 

Ankomah A, Ganle JK, Lartey MY, Kwara A, Nortey PA, Okyerefo MPK, et al. ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study. BMC Infect Dis. 2016;16(1):1–12.

Article  Google Scholar 

King R, Matovu JN, Rujumba J, Wavamunno P, Amone A, Gabagaya G, et al. PMTCT option B+ 2012 to 2018—taking stock: barriers and strategies to improve adherence to option B+ in urban and rural Uganda. Afr J AIDS Res. 2020;19(2):135–46.

Article  PubMed  Google Scholar 

Stranix-Chibanda L, Brummel S, Pilotto J, Mutambanengwe M, Chanaiwa V, Mhembere T, et al. Slow acceptance of universal antiretroviral therapy (ART) among mothers enrolled in IMPAACT PROMISE studies across the globe. AIDS Behav. 2019;23(9):2522–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moges NA, Adesina OA, Okunlola MA, Berhane Y. Same-day antiretroviral treatment (ART) initiation and associated factors among HIV positive people in Northwest Ethiopia: baseline characteristics of prospective cohort. Archiv Pub Health. 2020;78(1):1–13.

Google Scholar 

留言 (0)

沒有登入
gif